Markedly elevated levels of plasma advanced glycation end products in patients with liver cirrhosis - Amelioration by liver transplantation

Journal of Hepatology

Volumn 36, Issue 1, 2002, Pages 66-71

  Šebeková, Katarína ^a   Kupčová, Viera ^a   Schinzel, Reinhard ^b   Heidland, August ^b  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Cystatin C; Liver cirrhosis; Liver transplantation; N carboxymethyllysine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMIN; DEETHYLLIDOCAINE; SCAVENGER RECEPTOR;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BLOOD LEVEL; CONTROLLED STUDY; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVER WEIGHT; MACROMOLECULE; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CREATININE; CYSTATINS; FEMALE; GLOMERULAR FILTRATION RATE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; KIDNEY FAILURE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LYSINE; MALE; MIDDLE AGED;

EID: 0036126560     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00232-X     Document Type: Article

References (23)

1. Advanced protein glycosylation in diabetes and aging
2. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA
3. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging
4. Two novel rat liver membrane proteins that bind advanced glycation end products: Relationship to macrophage receptor for glucose-modified proteins
5. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusiodal Kupffer and endothelial cells
6. Endocytic uptake of advanced glycation end products by mouse liver sinusoidal cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor class A
7. Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products
8. Molecular identity and cellular distribution of advanced glycation endproduct receptors: Relationship of p60 to OST-48 and p90 to 80-K-H membrane proteins
9. Transection of the oesophagus for bleeding oesophageal varices
10. Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity
11. Low-molecular but not high-molecular AGEs are removed by high-flux hemodialysis
12. Lidocaine metabolite formation as a measure of liver function in patients with cirrhosis
13. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II)
14. Serum cystatin C as an endogenous parameter of the renal function in patients with normal to moderately impaired kidney function
15. Enhanced plasma levels of advanced glycation end products (AGEs) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation-are they inter-related?
16. ε-(carboxymethyl)lysine levels in type 2 diabetic patients: Role of renal function
17. Relevance of oxidative and carbonyl stress to long-term uremic complications
18. Renal fate of circulating advanced glycation end products (AGE): Evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cells
19. Monitoring oxidative damage in patients with liver cirrhosis and different daily alcohol intake
20. Endotoxaemia in liver cirrhosis: Treatment with Polymyxin B
21. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging
22. Insulin enhances macrophage scavenger receptor-mediated endocytic uptake of advanced glycation end products
23. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications